Drug
Human Normal Immunoglobulin For Administration
Human Normal Immunoglobulin For Administration: highest development phase Phase 3, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Human Normal Immunoglobulin for Subcutaneous Administration NCT00419341 | Phase 3 | Primary Immune Deficiency |
Latest
No recent events.
Follow Human Normal Immunoglobulin For Administration on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.